1. FES avid pulmonary adenocarcinoma and confounding ER+ breast carcinoma
- Author
-
Yousif M. Abdelmoneim, MD, Yanyan Lou, MD PhD, Pooja Advani, MD, Andras Khoor, MD PhD, Akash Sharma, MD, and Ephraim E. Parent, MD PhD
- Subjects
Estrogen receptor ,FES ,Pulmonary adenocarcinoma ,Breast carcinoma ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
Breast carcinomas are well known for expression of estrogen receptor (ER) however there are other malignancies that are also express ER, possibly confounding the diagnostic interpretation of 16α-[18F]fluoro-17β-estradiol (FES; Cerianna GE HealthCare) in patients with both ER+ breast carcinomas and other malignancies. We present a case of a woman with prior history of both ER+ breast carcinoma and pulmonary adenocarcinoma with subsequent identification of an FES pulmonary nodule that was proven on histopathology to be consistent with an ER expressing pulmonary adenocarcinoma metastasis
- Published
- 2025
- Full Text
- View/download PDF